Powerful New Tools to Diagnosis Blood Cancers in Development
Scientists are using new technology to improve the diagnosis and treatment of blood cancers, which affect 1.24 million people globally.
Category: Leukemia
Leukemia
Latest
Leukemia
Latest
Study Offers Promise for Early Detection of Infections among Childhood Leukemia Patients
A noninvasive blood test may provide a ‘crystal ball’ for early detection of infections, leading to increased cure rates among pediatric leukemia patients.
Leukemia
Latest
Elevating Pathology
AI-driven digital pathology can accelerate cancer diagnosis and clinical trial recruitment.
Bio-Rad Releases First FDA-Cleared Liquid Biopsy Test for Chronic Myeloid Leukemia
Using the kit, clinicians can accurately and reproducibly monitor residual disease in patients with chronic myeloid leukemia, even at low levels.
Read More
FDA Grants Clearance for OGT’s AML/MDS FISH Probes
Clearance enables accurate and easy-to-interpret AML and MDS detection with reduced validation burden.
Read More
Determining Molecular Response in Chronic Myeloid Leukemia
Droplet digital PCR can provide a more accurate assessment of low levels of BCR-ABL mRNA than quantitative real-time PCR.
Read More
Qiagen Broadens GeneReader NGS System Applications into Hereditary Disease Analysis
New applications include customizable QIAact target enrichment panels for next-generation sequencing of more than 13 hereditary disease groups.
Read More
SeraCare Releases NGS Reference Material for Hematologic Malignancies
SeraCare Life Sciences has expanded its suite of clinical genomics development, validation, and quality control tools with the launch of Seraseq myeloid DNA and myeloid RNA fusion reference materials.
Read More
Bio-Rad Launches Digital PCR Test for Monitoring Chronic Myeloid Leukemia Response to Therapy
Bio-Rad Laboratories has introduced the QXDx BCR-ABL %IS kit, a CE-marked digital polymerase chain reaction test that can monitor the molecular response to therapy of patients with chronic myeloid leukemia.
Read MoreFDA Grants Clearance for Chronic Myeloid Leukemia Test
Agency allows marketing of the QuantideX qPCR BCR-ABL IS kit, the first nucleic acid-based quantitation test for use during treatment of rare leukemia.
Read More
RainDance Technologies Forms Hematologic Oncology Consortium
After its ASH 2014 debut, the RainDance HemOnc Consortium, an international panel of clinical research experts, will focus on developing assays for liquid biopsy research of myeloid disorders.
Read MorePathGroup Collaboration to Offer Genomic Profiling of Hematologic Malignancies
A new collaboration plans to provide genomic profiling and information for patients that have been unsuccessful on repeated therapy for the group of cancers that include leukemias, lymphomas, and myeloproliferative and myelodysplastic diseases.
Read More
Sequenta Introduces ClonoSIGHT, Sequencing-Based MRD Test for Leukemia, Lymphoma
The test has been shown to offer sensitivity for the detection of residual cancer cells in marrow or blood.
Read MoreTesting for Lymphoma and Leukemia
With so many types of lymphoma, there’s a wide range of corresponding lab tests to detect their presence in patients. Here, CLP takes a look at testing for the most common type of lymphoma (diffuse large B-cell
Read More